Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined PKCiota and mTOR Inhibition for Treatment of Advanced Squamous Lung Cancer

NCT01383668 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01383668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01383668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined PKCiota and mTOR Inhibition for Treatment of Advanced Squamous Lung Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Withdrawn
Start date
June 30, 2011
Completion date
February 8, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent non-small cell lung cancer, squamous cell lung cancer, stage iiia non-small cell lung cancer, stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer, unspecified adult solid tumor, protocol specific